Search

Your search keyword '"Filler, Guido"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Filler, Guido" Remove constraint Author: "Filler, Guido" Publisher springer international Remove constraint Publisher: springer international
59 results on '"Filler, Guido"'

Search Results

3. Limitations of U25 CKiD and CKD-EPI eGFR formulae in patients 2-20 years of age with measured GFR > 60 mL/min/1.73 m 2 -a cross-sectional study.

4. Sex differences of burosumab in children with X-linked hypophosphataemic rickets.

6. Impact of the 2022 American Heart Association pediatric ambulatory blood pressure monitoring statement on the diagnosis of hypertension.

8. Effects of pediatric chronic kidney disease and its etiology on tissue sodium concentration: a pilot study.

11. Management of severe polyuria in idiopathic Fanconi syndrome.

12. Low agreement between kidney volume and kidney length z-scores.

14. Educational review: role of the pediatric nephrologists in the work-up and management of kidney stones.

15. Nephrological and urological complications of homozygous c.974G>A (p.Arg325Gln) OSGEP mutations.

16. Educational review: measurement of GFR in special populations.

17. Generic immunosuppressants.

19. Spot urine protein to creatinine ratio.

20. The compelling case for therapeutic drug monitoring of mycophenolate mofetil therapy.

21. Can the new CKD-EPI BTP-B2M formula be applied in children?

22. Developmental changes of MPA exposure in children.

23. Should we stop dosing steroids per body surface area for nephrotics?

24. A step forward towards accurately assessing glomerular filtration rate in newborns.

25. Tandem hemodialysis and plasma exchange.

26. Trace elements in dialysis.

27. Methods of assessing renal function.

28. Nighttime blood pressure, systolic blood pressure variability, and left ventricular mass index in children with hypertension.

29. Cystatin C adaptation in the first month of life.

30. Native kidney BK virus nephropathy associated with acute lymphocytic leukemia.

32. Why multidisciplinary clinics should be the standard for treating chronic kidney disease.

33. High prevalence of elevated lead levels in pediatric dialysis patients.

34. Should we consider MMF therapy after rituximab for nephrotic syndrome?

35. Steroid-resistant acute allograft rejection in renal transplantation.

36. Residual renal function assessment with cystatin C.

37. Are we ready to use aliskiren in children?

38. Age-related stature and linear body segments in children with X-linked hypophosphatemic rickets.

39. Rituximab in refractory nephrotic syndrome.

40. Development of a beta-trace protein based formula for estimation of glomerular filtration rate.

41. Adherence to waiting-time targets for pediatric nephrology clinic referrals.

42. Bicarbonate therapy improves growth in children with incomplete distal renal tubular acidosis.

43. Role of mycophenolate mofetil in remission maintenance after a successful response to rituximab.

44. Novel HGPRT 293 A>G point mutation presenting as neonatal acute renal failure.

45. How to define anemia in children with chronic kidney disease?

46. Growth impairment shows an age-dependent pattern in boys with chronic kidney disease.

47. Calcineurin inhibitors in pediatric renal transplant recipients.

48. Unexpectedly high exposure to enteric-coated mycophenolate sodium upon once-daily dosing.

49. Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate.

50. Icodextrin re-absorption varies with age in children on automated peritoneal dialysis.

Catalog

Books, media, physical & digital resources